top of page
OUR MISSION
Developing a new and improved vaccine targeting multiple developmental stages of Plasmodium falciparum.
Main goals
> Optimise the efficacy of current pre-erythrocytic vaccines while evaluating the safety and immunogenicity of new blood-stage mRNA vaccine candidates.
​
> Develop the next generation of highly efficacious malaria vaccine candidates using an advanced in-silico platform to analyse TCR- and single-cell sequencing data in combination with artificial intelligence (AI) based predictions of novel malaria vaccine antigens.
​
> Establish a European facility for the production of malaria sporozoites for research and clinical use.
bottom of page